Medtronic plc (MDT)
Summary
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started
I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.
Medtronic: A Near Decade High Dividend For This Aristocrat
Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.
Medtronic plc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 69,091 | $5.83M | $5.75M | -$84,875.58 | -1.46% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 1,237 | $108,982.41 | $102,918.4 | -$6,064.01 | -5.56% |
| MSH Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 708,496 | $59.3M | $58.95M | -$357,190.15 | -0.6% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 902 | $78,484.94 | $75,046.4 | -$3,438.54 | -4.38% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 12,213 | $1.25M | $1.02M | -$234,317.53 | -18.74% |
Medtronic plc (MDT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Medtronic plc ever had a stock split?
Medtronic plc Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Geoffrey Straub Martha CEO | NYSE Exchange | G5960L103 CUSIP |
| US Country | 95,000 Employees | 26 Jun 2026 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Overview
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Products and Services
Medtronic’s comprehensive range of products and services is categorized into four primary segments:
- Cardiovascular Portfolio: This segment offers advanced device-based solutions for cardiac care, including:
- Implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices for heart rhythm management.
- Cardiac ablation products for treating atrial fibrillation.
- Insertable cardiac monitor systems for continuous heart monitoring.
- TYRX products, which involve antimicrobial envelopes for electronic implantable devices.
- Aortic valves, surgical valve replacement and repair products, transcatheter pulmonary valves, and endovascular stent grafts for structural heart disease treatment.
- Percutaneous coronary intervention products and angioplasty balloons for coronary artery disease treatment.
- Remote monitoring and patient-centered software for enhanced patient care.
- Medical Surgical Portfolio: This segment encompasses a broad array of surgical instruments and devices, including:
- Surgical stapling devices and vessel sealing instruments for precise surgical procedures.
- Wound closure products and electrosurgery products aimed at efficient surgical recovery.
- Surgical artificial intelligence and robotic-assisted surgery products for advanced surgical techniques.
- Hernia mechanical devices and mesh implants, along with other gynecology and lung health products.
- Minimally invasive gastrointestinal and hepatologic diagnostic and therapy tools, patient monitoring, airway management and ventilation therapies, and renal disease treatments.
- Neuroscience Portfolio: This segment delivers solutions for the central nervous system and supportive structures, including:
- Products for spinal, neuro, and orthopedic surgeries, pain management, and urology.
- Energy surgery instruments and image-guided surgery systems for enhanced surgical accuracy.
- Intra-operative imaging and robotic guidance systems for spine procedures.
- Therapies for brain vasculature conditions.
- Diabetes Operating Unit: Focused on diabetes management, this segment offers:
- Insulin pumps and consumables for continuous insulin delivery.
- Continuous glucose monitoring systems for real-time blood glucose tracking.
- Smart insulin pen systems and related consumables for modern diabetes care.
